Slow-MAS NMR Metabolomics
Slow-MAS NMR Metabolomics
批准号:
8416150
负责人:
Jian Zhi Hu
金额:
$41.1万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-15 至 2016-06-30
关键词:
AddressAgeArteriesAtherosclerosisBiochemicalBiologicalBiological MarkersBiomedical ResearchBiopsyBiopsy SpecimenBlood specimenC57BL/6 MouseClinicalClinical ResearchComplementDataDetectionDevelopmentDietDiseaseExtravasationGene ExpressionGoalsInsectaInvestigationKnowledgeLaboratoriesLaboratory AnimalsLearningLifeLiquid substanceMagicMetabolicMetabolic DiseasesMetabolic PathwayMethodsMusNational Institute of Environmental Health SciencesObese MiceObesityOperative Surgical ProceduresOrganOutcomePatientsPerformancePhysiologic pulsePositioning AttributeProteomicsProtocols documentationResearchResolutionRisk FactorsSamplingSkeletal MuscleTechniquesTechnologyTimeTissue SampleTissuesTranslational ResearchWorkbasecell typedesignimprovedmagnetic fieldmetabolomicsmilliliterminimally invasivemouse modelnanolitrenovelresearch clinical testingresearch studysealsuccesstime usetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): High resolution magic angle spinning (hr-MAS) NMR where a sample spinning rate of a few kHz or more is used has become a powerful tool for metabolic profiling of intact biological tissues. However, there are a few critical issues that nee be addressed in order for MAS NMR to be used widely in biomedical, clinical, and translational researches. First, hr-MAS technique is destructive due to the large centrifugal force associated with fast sample spinning. Second, the sample volume in an hr-MAS experiment is restricted to ~15 to 60 ml also due to a variety of technical challenges associated with fast spinning. The goal of our research is to develop a non-destructive, high resolution and high sensitivity MAS-NMR method that complements hr-MAS for metabolomics investigations. To reach our goal, we have formulated two specific Aims. Aim 1: Development of a non-destructive MAS NMR metabolomics technique by using slow sample spinning, including a slow-MAS probe and rotor position synchronized slow-MAS pulse sequences on a 500 MHz NMR spectrometer. The slow-MAS technology will be capable of high resolution and high sensitivity metabolic profiling on biological tissue samples with volume variable from as small as 200 nanoliters (nL) to as large as 1000 microliters (1.0 cm3) or more using a single probe. The nL capability will make it possible to follow the metabolic changes through a continued investigation on a single small laboratory animal, and ultimately on a patient, over a long period of time using minimally invasive tissue biopsy and blood samples. The micro-liter to cm3 capability will serve the wide spread need of metabolic profiling on intact biological tissues of variable sizes, thus enabling large scale metabolic profiling on intact tissues. We have successfully performed concept- proven experiment on a 300 MHz NMR spectrometer using a concept-proven slow-MAS NMR probe to justify our proposed research. Aim 2: Application of the nL slow-MAS method. We will apply the nL feature of the slow-MAS probe to continuously follow the metabolic changes using minimal invasive biopsy skeletal muscle and blood samples of 200 to 500 nL in volume on 8 obese C57BL/6 mice, and 8 normal C57BL/6 mice (controls) over ages 8 to 16 weeks to identify possible metabolite biomarkers that are related to obesity. At the end of the in life sampling, the
mice will be sacrificed and whole organs will be studied using the cm3 feature of the probe. We will also carry out slow-MAS metabolomics studies on artery excised from an obese- accelerated atherosclerosis mouse model. Obesity has become a recognized risk factor for a variety of metabolic disorders, including in particular atherosclerotic cardiovascular diseases. However, the disordered metabolic pathways that contribute to obesity-accelerated atherosclerosis are not well established. This is mainly due to the difficulties of direct metaboli profiling on very small amount of tissue samples. Our nL slow- MAS capability will make the metabolic profiling on the intact artery excised from a diet-induced obese + atherosclerosis mouse model possible.
PUBLIC HEALTH RELEVANCE: We propose to develop a non-destructive magic angle spinning metabolomics technique that is capable of high resolution and high sensitivity metabolic profiling on biological samples, in particular, on tissue samples with sample volume from as small as 200 nanoliters (nL) to as large as a milliliter or more using a single probe and using only a few minutes. If successful, this technique will enable large scale metabolic profiling
on intact biological tissues of various sizes that will have wide application in biomedical, clinicl and translational researches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A State-of-Art NMR technique to Investigate Biologicals Effects of Electronic Nicotine Delivery Systems
-
批准号:10017237
-
项目类别:
-
资助金额:$21.31万
-
财政年份:2019
-
负责人:Jian Zhi Hu
-
依托单位:
Slow-MAS NMR Metabolomics
-
批准号:8687652
-
项目类别:
-
资助金额:$41.2万
-
财政年份:2012
-
负责人:Jian Zhi Hu
-
依托单位:
Slow-MAS NMR Metabolomics
-
批准号:8545851
-
项目类别:
-
资助金额:$39.87万
-
财政年份:2012
-
负责人:Jian Zhi Hu
-
依托单位:
Development of a nanoliter slow-MAS NMR metabolomics probe
-
批准号:7896628
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:Jian Zhi Hu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: